Medicare Enrolled
Dr. Alfred Kalman, M.D.
Hematology & Oncology · Coral Springs, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kalman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kalman? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kalman
Dr. Alfred Kalman is a hematology & oncology in Coral Springs, FL, with 20 years in practice. Based on federal Medicare data, Dr. Kalman performed 15,472 Medicare services across 1,657 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kalman received a total of $40,051 from 80 pharmaceutical and/or device companies across 1276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kalman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 23% volume in FL$ $40,051 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,472
Medicare services
Top 23% in FL for hematology & oncology
1,657
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~774 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 2,790 | $2 | $7 |
| Epoetin alfa injection (Retacrit) for anemia | 2,210 | $6 | $20 |
| Denosumab injection (Prolia/Xgeva) | 1,740 | $18 | $54 |
| Blood draw (venipuncture) | 1,560 | $7 | $8 |
| Anti-nausea injection (ondansetron/Zofran) | 1,544 | $0 | $3 |
| Complete blood count (CBC) with differential | 1,531 | $8 | $19 |
| Dexamethasone injection (steroid) | 1,092 | $0 | $0 |
| Office visit, established patient (20-29 min) | 523 | $66 | $229 |
| Office visit, established patient (30-39 min) | 332 | $99 | $324 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 301 | $51 | $161 |
| Ferritin level test (iron stores) | 279 | $13 | $78 |
| Hospital follow-up visit, high complexity | 227 | $97 | $304 |
| Administration of chemotherapy into vein, 1 hour or less | 201 | $104 | $335 |
| Injection of additional new drug or substance into vein | 172 | $12 | $39 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 169 | $23 | $29 |
| Drug injection, under skin or into muscle | 166 | $11 | $35 |
| Vitamin B-12 level test | 110 | $15 | $100 |
| Initial hospital admission, high complexity | 103 | $142 | $442 |
| Folic acid level test | 94 | $14 | $88 |
| Administration of chemotherapy into vein, each additional hour | 92 | $23 | $72 |
| Carcinoembryonic antigen (cea) protein level | 72 | $19 | $47 |
| Injection, diphenhydramine hcl, up to 50 mg | 59 | $1 | $3 |
| New patient office visit, complex (60-74 min) | 54 | $165 | $237 |
| PSA test (prostate cancer screening) | 40 | $18 | $46 |
| Office visit, established patient, complex (40-54 min) | 11 | $145 | $453 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.0% high complexity
65.1% medium
31.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$40,051
Total received (2018-2024)
Avg $5,722/year across 7 years
Top 17% in FL for hematology & oncology
80
Companies
1,276
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,421 (51.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,930 (39.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,700 (9.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,186
2023$2,766
2022$6,283
2021$3,498
2020$4,318
2019$5,317
2018$15,683
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Pharmacyclics LLC, An AbbVie Company
$5,574
Exelixis Inc.
$3,878
AbbVie, Inc.
$3,558
Incyte Corporation
$3,542
Janssen Biotech, Inc.
$2,421
AstraZeneca Pharmaceuticals LP
$1,983
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,779
BeiGene USA, Inc.
$1,726
E.R. Squibb & Sons, L.L.C.
$1,510
PFIZER INC.
$1,429
Lilly USA, LLC
$897
Novartis Pharmaceuticals Corporation
$759
Amgen Inc.
$735
GENZYME CORPORATION
$696
Takeda Pharmaceuticals U.S.A., Inc.
$600
Genentech USA, Inc.
$599
BeiGene, Ltd.
$525
Eisai Inc.
$502
Merck Sharp & Dohme Corporation
$480
EISAI INC.
$460
Seagen Inc.
$424
Celgene Corporation
$367
Foundation Medicine, Inc.
$362
JAZZ PHARMACEUTICALS INC.
$325
Bayer HealthCare Pharmaceuticals Inc.
$274
ABBVIE INC.
$267
Rigel Pharmaceuticals, Inc.
$258
Astellas Pharma US Inc
$246
Gilead Sciences, Inc.
$192
Puma Biotechnology, Inc.
$188
Ipsen Biopharmaceuticals, Inc
$185
Seattle Genetics, Inc.
$180
Alexion Pharmaceuticals, Inc.
$176
TerSera Therapeutics LLC
$152
Deciphera Pharmaceuticals Inc.
$146
AbbVie Inc.
$140
GlaxoSmithKline, LLC.
$129
PUMA BIOTECHNOLOGY, INC.
$126
Bayer Healthcare Pharmaceuticals Inc.
$125
TOLMAR Pharmaceuticals, Inc.
$115
Adaptive Biotechnologies Corporation
$114
EMD Serono, Inc.
$111
Dova Pharmaceuticals
$111
Janssen Pharmaceuticals, Inc
$99
ARRAY BIOPHARMA INC
$95
Karyopharm Therapeutics Inc.
$94
MEDIVATION FIELD SOLUTIONS LLC
$89
Merck Sharp & Dohme LLC
$88
Clovis Oncology, Inc.
$78
Taiho Oncology, Inc.
$77
Verastem, Inc.
$76
Regeneron Healthcare Solutions, Inc.
$74
Teva Pharmaceuticals USA, Inc.
$73
SERVIER PHARMACEUTICALS LLC
$70
Sobi, Inc
$69
Mirati Therapeutics, Inc.
$64
Daiichi Sankyo Inc.
$58
Spectrum Pharmaceuticals Inc.
$51
Amneal Pharmaceuticals LLC
$43
SANOFI-AVENTIS U.S. LLC
$41
Sun Pharmaceutical Industries Inc.
$40
TESARO, Inc.
$39
Kyowa Kirin, Inc.
$35
Advanced Accelerator Applications
$31
Octapharma USA, Inc.
$25
Pharmacosmos Therapeutics Inc.
$24
AVEO Pharmaceuticals, Inc.
$23
ImmunoGen, Inc.
$22
Sandoz Inc.
$21
Tolmar, Inc.
$21
Organon LLC
$21
Verity Pharmaceuticals Inc.
$20
Acceleron Pharma, Inc.
$18
Heron Therapeutics, Inc.
$18
Ethicon US, LLC
$17
Stemline Therapeutics Inc.
$16
PORTOLA PHARMACEUTICALS, INC.
$15
Helsinn Therapeutics (U.S.), Inc.
$14
Agios Pharmaceuticals, Inc.
$13
Array BioPharma Inc.
$12
Top 3 companies account for 32.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · Alecensa · Aliqopa · Avastin · BENDEKA · BEVYXXA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHANTIX · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · EVENITY · Elahere · Enhertu · Erleada · FARESTON · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Folotyn · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAPLAS · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROMACTA · Perjeta · Pomalyst · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trelstar · Trodelvy · ULTOMIRIS · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · WILATE · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xofigo · YONSA · YONSA (abiraterone acetate) · ZARXIO · ZEJULA · ZEPZELCA · ZIIHERA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (51%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $259 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
115
Per 100K population
5.9
County median income
$74,534
Nearest hospital
BROWARD HEALTH CORAL SPRINGS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kalman is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), and high industry engagement (low-engagement, top 17%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kalman experienced with injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg?
Based on Medicare claims data, Dr. Kalman performed 2,790 injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kalman receive payments from pharmaceutical companies?
Yes. Dr. Kalman received a total of $40,051 from 80 companies across 1,276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kalman's costs compare to other hematology & oncologys in Coral Springs?
Dr. Kalman's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kalman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Coral Springs
Browse hematology & oncologys in Coral Springs ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Pharmacyclics LLC, An AbbVie Company Payments to Doctors
See all physicians who received payments from Pharmacyclics LLC, An AbbVie Company.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc..
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology